222 related articles for article (PubMed ID: 9479826)
1. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
Chellappan SP; Giordano A; Fisher PB
Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
[No Abstract] [Full Text] [Related]
2. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG
Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786
[TBL] [Abstract][Full Text] [Related]
3. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
Awad MM; Sanders JA; Gruppuso PA
FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
6. CDK inhibitors: positive and negative regulators of G1-phase progression.
Sherr CJ; Roberts JM
Genes Dev; 1999 Jun; 13(12):1501-12. PubMed ID: 10385618
[No Abstract] [Full Text] [Related]
7. The INK4 family of CDK inhibitors.
Carnero A; Hannon GJ
Curr Top Microbiol Immunol; 1998; 227():43-55. PubMed ID: 9479825
[No Abstract] [Full Text] [Related]
8. Inhibitors of the Cip/Kip family.
Hengst L; Reed SI
Curr Top Microbiol Immunol; 1998; 227():25-41. PubMed ID: 9479824
[No Abstract] [Full Text] [Related]
9. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
Ragione FD; Iolascon A
Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
[TBL] [Abstract][Full Text] [Related]
10. Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice.
Kiyokawa H; Koff A
Curr Top Microbiol Immunol; 1998; 227():105-20. PubMed ID: 9479827
[No Abstract] [Full Text] [Related]
11. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
Schreiber M; Muller WJ; Singh G; Graham FL
Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
Gray-Bablin J; Rao S; Keyomarsi K
Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.
Matsumura I; Ishikawa J; Nakajima K; Oritani K; Tomiyama Y; Miyagawa J; Kato T; Miyazaki H; Matsuzawa Y; Kanakura Y
Mol Cell Biol; 1997 May; 17(5):2933-43. PubMed ID: 9111365
[TBL] [Abstract][Full Text] [Related]
17. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours.
Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
Int J Cancer; 2000 Feb; 85(3):370-5. PubMed ID: 10652429
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
Alcorta DA; Xiong Y; Phelps D; Hannon G; Beach D; Barrett JC
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13742-7. PubMed ID: 8943005
[TBL] [Abstract][Full Text] [Related]
20. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins.
Hall M; Bates S; Peters G
Oncogene; 1995 Oct; 11(8):1581-8. PubMed ID: 7478582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
